US Weekly IPO and SPAC Monitor: Biotech Acrivon Therapeutics and Online Games Developer Snail

There are two deals due to price in the week ahead, Precision oncology biotech Acrivon Therapeutics (ACRV) plans to raise $100 million and holdover Intensity Therapeutics (INTS) plans to raise $10 million  Online games developer Snail is also expected to Price. There is a chance some micro-caps may IPO they have been looking to price on a “day-to-day” basis as brokers look to shift deals in the pipeline to investors. The dismal IPO market continued with no new IPO pricings last week in fact … Continue reading US Weekly IPO and SPAC Monitor: Biotech Acrivon Therapeutics and Online Games Developer Snail